InvestorsHub Logo

DewDiligence

11/10/18 4:21 PM

#222131 RE: rfj1862 #222130

Was that analysis really and truly prespecified? It’s not listed as one of the myriad secondary endpoints in the REDUCE-IT listing on ct.gov (https://www.clinicaltrials.gov/ct2/show/NCT01492361 ).